Combining Umifenovir, Favipiravir for mild COVID treatment did not show benefit: Glenmark MD Bureau9 Oct 2020 9:05 PM ISTThe addition of Umifenovir did not demonstrate any additional benefit over Favipiravir alone in moderate Covid-19 patients, Glenmark said.
Madras HC directs to constitute committee to diminish reliance on China for API imports MD Bureau9 Oct 2020 5:20 PM ISTAccording to the order, the proposed committee would facilitate the necessary requirements of Vinkem Labs, including fiscal and regulatory for...
Setback to Dr Reddys: CDSCO panel rejects proposal to test Covid vaccine Sputnik-V due to inadequate data Ruchika Sharma8 Oct 2020 4:06 PM ISTThe recommendations by an expert panel of the Central Drugs Standard Control Organisation (CDSCO) noted that safety and immunogenicity data from...
Five months after COVID crisis, drug sales report growth of 4.5 percent at Rs 13170 crore: AIOCD-AWACS Report Farhat Nasim7 Oct 2020 5:41 PM ISTNew Delhi: The Indian Pharma Market for the first time has come back very strongly after 5 months of the COVID crisis and registered a growth of 4.5%...
Nikhil Chopra to now spearhead JB Chemicals, appointed as Director, CEO Ruchika Sharma6 Oct 2020 12:49 PM ISTNew Delhi: Former Cipla India Business Head, Nikhil Chopra, will now lead J B Chemicals & Pharmaceuticals as its's board has appointed him as...
Intellectual Property Apellate Board stays cancellation of Novartis patent for Anti-Cancer Drug Ceritinib Farhat Nasim5 Oct 2020 3:33 PM ISTNew Delhi: The Intellectual Property Apellate Board (IPAB) has recently stayed the cancellation of the Swiss drugmaker Novartis' patent over the...
Patent Infringement: Sun Pharma sued by Orexo over generic opioid dependence drug Zubsolv Farhat Nasim4 Oct 2020 11:15 AM ISTNew Delhi: In a major setback to Sun Pharmaceutical Industries Limited, Swedish drugmaker Orexo recently filed a patent infringement action in the...
Biological E, ICMR to develop COVID treatment by injecting inactivated SARS-CoV2 in horses Ruchika Sharma3 Oct 2020 2:01 PM ISTThe 'antisera' is yet to undergo human clinical trials to establish its safety and efficacy and the Drugs Controller General of India (DCGI) would be...
Ceiling price of 21 scheduled formulations revised by allowing one-time price increase by 50 percent: Minister Ruchika Sharma2 Oct 2020 11:00 AM ISTNew Delhi: Apprising on the upward price revision of commonly used medicines like antibiotics, anti-allergies, anti-malaria drugs, BCG vaccine, and...
NPPA caps medical oxygen prices to curb black marketing Ruchika Sharma1 Oct 2020 12:41 PM ISTNew Delhi: Through a recent Gazette Notification, the Ministry of Health and Family Welfare (MoHFW) has directed the National Pharmaceutical Pricing...
NPPA fixes retail price of 26 formulations; Details Farhat Nasim30 Sept 2020 3:51 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
Setback: Himachal HC junks Digital Vision Pharma plea on cough syrup Coldbest PC testing Farhat Nasim29 Sept 2020 1:07 PM ISTShimla: Upholding the Sirmaur Chief Judicial Magistrate (CJM) order allowing the drug inspector to take additional samples of the seized syrup, the...
